JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M802406200 on May 12, 2008

J. Biol. Chem., Vol. 283, Issue 28, 19301-19313, July 11, 2008
This Article
Free via Author's Choice: AC
Right arrow AC Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrowAC All Versions of this Article:
283/28/19301    most recent
M802406200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Livesey, M. R.
Right arrow Articles by Peters, J. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Livesey, M. R.
Right arrow Articles by Peters, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor*Formula

Matthew R. Livesey{ddagger}1, Michelle A. Cooper{ddagger}, Tarek Z. Deeb§, Jane E. Carland{ddagger}, Janna Kozuska{ddagger}, Tim. G. Hales§, Jeremy J. Lambert{ddagger}2, and John A. Peters{ddagger}23

From the {ddagger}Neurosciences Institute, Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, United Kingdom and the §Departments of Pharmacology and Physiology and Anesthesiology and Critical Care Medicine, George Washington University, Washington, D. C. 20037

Cation-selective cysteine (Cys)-loop transmitter-gated ion channels provide an important pathway for Ca2+ entry into neurones. We examined the influence on Ca2+ permeation of amino acids located at intra- and extracellular ends of the conduction pathway of the human 5-hydroxytryptamine type 3A (5-HT3A) receptor. Mutation of cytoplasmic arginine residues 432, 436, and 440 to glutamine, aspartate, and alanine (the aligned residues of the human 5-HT3B subunit (yielding 5-HT3A(QDA)) increased PCa/PCs from 1.4 to 3.7. The effect was attributable to the removal of an electrostatic influence of the Arg-436 residue. Despite its relatively high permeability to Ca2+, the single channel conductance of the 5-HT3A(QDA) receptor was depressed in a concentration-dependent and voltage-independent manner by extracellular Ca2+. A conserved aspartate, located toward the extracellular end of the conduction pathway and known to influence ionic selectivity, contributed to the inhibitory effect of Ca2+ on macroscopic currents mediated by 5-HT3A receptors. We introduced a D293A mutation into the 5-HT3A(QDA) receptor (yielding the 5-HT3A(QDA D293A) construct) to determine whether the aspartate is required for the suppression of single channel conductance by Ca2+. The D293A mutation decreased the PCa/PCs ratio to 0.25 and reduced inwardly directed single channel conductance from 41 to 30 pS but did not prevent suppression of single channel conductance by Ca2+. The D293A mutation also reduced PCa/PCs when engineered into the wild-type 5-HT3A receptor. The data helped to identify key residues in the cytoplasmic domain (Arg-436) and extracellular vestibule (Asp-293) that markedly influence PCa/PCs and additionally directly demonstrated a depression of single channel conductance by Ca2+.


Received for publication, March 27, 2008 , and in revised form, May 8, 2008.

Author's Choice—Final version full access.

* This work was supported in part by grants from the Wellcome Trust (to J. J. L. and J. A. P.), from Tenovus Scotland and the Anonymous Trust (to J. A. P.), and from the National Science Foundation (to T. G. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. 1.

1 Supported by a Biotechnology and Biological Sciences Research Council-Case studentship in conjunction with Eli Lilly and Co.

2 Supported by a grant from Eli Lilly and Co.

Author's Choice

3 To whom correspondence should be addressed: Neurosciences Inst., Division of Pathology and Neuroscience, Ninewells Hospital and Medical School, The University of Dundee, Dundee DD19SY, Scotland, United Kingdom. Tel.: 44-1382-660111; Fax: 44-1382-667120; E-mail: j.a.peters{at}dundee.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.